Colorado Blood Cancer Institute Medical Group Revenue and Competitors
Estimated Revenue & Valuation
- Colorado Blood Cancer Institute Medical Group's estimated annual revenue is currently $22.4M per year.
- Colorado Blood Cancer Institute Medical Group's estimated revenue per employee is $270,000
Employee Data
- Colorado Blood Cancer Institute Medical Group has 83 Employees.
- Colorado Blood Cancer Institute Medical Group grew their employee count by 8% last year.
Colorado Blood Cancer Institute Medical Group's People
Name | Title | Email/Phone |
---|
Colorado Blood Cancer Institute Medical Group Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $359.5M | 951 | 11% | N/A | N/A |
#2 | $12.6M | 52 | 21% | N/A | N/A |
#3 | $7.8M | 36 | 0% | N/A | N/A |
#4 | $106.3M | 315 | 5% | N/A | N/A |
#5 | $137M | 406 | 17% | N/A | N/A |
#6 | $1881.3M | 4977 | 1105% | N/A | N/A |
#7 | $6.9M | 32 | 3% | N/A | N/A |
#8 | $6.9M | 32 | 3% | N/A | N/A |
#9 | $7.8M | 36 | 0% | N/A | N/A |
#10 | $14.1M | 58 | 9% | N/A | N/A |
What Is Colorado Blood Cancer Institute Medical Group?
The Colorado Blood Cancer Institute Medical Group consists of the Physicians, Nurse Practitioners, and Physician Assistants providing patient care at the Colorado Blood Cancer Institute. CBCI is the region's leading center for blood cancer treatment and transplant, both in terms of volume and quality. CBCI is on the cutting edge of the latest research in coordination with the Sarah Cannon Research Network. CBCI leads the region in CAR T-Cell therapy and is becoming a nationally recognized center for autoimmune disease transplant.
keywords:N/AN/A
Total Funding
83
Number of Employees
$22.4M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $22.4M | 83 | 9% | N/A |
#2 | $20.3M | 83 | 8% | N/A |
#3 | $8.3M | 83 | -7% | N/A |
#4 | $14.9M | 83 | 20% | N/A |
#5 | $3.5M | 83 | 5% | N/A |